<DOC>
	<DOCNO>NCT02486406</DOCNO>
	<brief_summary>The purpose three part study evaluate pharmacokinetics ( Part 1 ) , safety/efficacy ( Part 2 ) , long-term follow-up ( Part 3 ) ombitasvir ( OBV ) , paritaprevir ( PTV ) , ritonavir ( RTV ) without dasabuvir ( DSV ) without ribavirin ( RBV ) pediatric subject genotype 1 4 chronic hepatitis C virus ( HCV ) infection .</brief_summary>
	<brief_title>A Study Evaluate Treatment Hepatitis C Virus Infection Pediatric Subjects</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>1 . Positive antiHCV Ab HCV RNA great equal 1000 IU/mL time screen . 2 . HCV genotype 1 enrollment Part 1 genotype 1 4 enrollment Part 2 . 3 . Parent legal guardian willingness ability provide write informed consent participant willing able give assent , appropriate age country . 1 . Women pregnant , breastfeed consider become pregnant 2 . Use know strong inducer inhibitor ( e.g. , gemfibrozil ) cytochrome P450 2C8 ( CYP2C8 ) participant receive dasabuvir , strong moderate inducer CYP3A , within 2 week 10 half life , whichever longer , respective medication/supplement prior study drug administration . 3 . Positive test result Hepatitis B surface antigen ( HbsAg ) antiHIV antibody ( HIV Ab ) test . 4 . Current enrollment another interventional clinical study , previous enrollment study , prior current use investigational commercially available antiHCV agent IFNs RBV receipt investigational product within 6 week prior study drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hepatitis C Genotype 4</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Hepatitis C Genotype 1</keyword>
	<keyword>Hepatitis C Virus</keyword>
</DOC>